Our data demonstrate the granulopoietic toxicity of aflatoxin B1 (AFB1)in vivo and show an impact of this mycotoxin on the production of some humoral regulatory factors dealing with the granulopoietic developmental pathway (CSA, IL-1, IL-2). The dose of AFB1 studied represented approximately 1/5 of LD50 for young male rats. An early suppressive effect of AFB1 towards CFU-GM was transient in treated animals. The peak in granulopoietic activity was preceded in time by an increased CSA and IL-1 formation. Elevated IL-2 synthesis and increased T cell activation paralleled the peak in granulopoietic activity.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
- AFB1 :
granulocyte-monocyte colony-forming unit
tumour necrosis factor
Bushby WF, Wogan GN. Aflatoxins. In: Searle CD, ed. Chemical carcinogens [ACS Monograph 182]. Washington DC, 1984: 945–1136.
Terao K. The effect of aflatoxin on chick-embryo liver cells. Exp Cell Res 1967; 48: 151–5.
Reddy RV, Taylor MJ, Sharma RP. Studies of immune function of CD-1 mice exposed to aflatoxin B1. Toxicology 1987; 43: 123–32.
Reddy RV, Sharma RP. Effects of aflatoxin B1 on murine lymphocytic functions. Toxicology 1989; 54: 31–44.
Reisudin, Singh KP, Zaidi SI, Saxena AK, Ray PK. Effect of aflatoxin on lymphoid cells of weanling rat. J Appl Toxicol 1990; 10: 245–50.
Wang CY, Yu XS, Hong JX, Lin TZ, Yang YQ. HLA related genetic control of natural killer activity and aflatoxin B1 suppression of lymphocytic blastogenesis. Chin Med J Engl 1987; 100: 29–33.
Herrmann F, Mertelsmann R. Polypeptides controlling hematopoietic cell development and activation, I: In vitro results. Blut 1989; 58: 117–28.
Metcalf D. The colony stimulating factors. Cancer 1990; 65: 2185–95.
Kelso A. Cytokines: structure, function and synthesis. Curr Opinion Immunol 1989; 2: 215–25.
Metcalf D. Hemopoietic colonies: In vitro cloning of normal and leukemic cells. Berlin/New York: Springer Verlag, 1977.
Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978; 120: 2027–32.
Karasuyama H, Tohyama N, Tada T. Autocrine growth and tumorigenicity of interleukin-2-dependent helper T-cells transfected with IL-2 gene. J Exp Med 1989; 169: 13–25.
Satsangi J, Wolstencroft RA, Cason J, Ainley CC, Dumonde DC, Thompson RPH. Interleukin 1 in Crohn's disease. Clin Exp Immunol 1987; 67: 594–605.
Jones AL, Millar JL. Growth factors in haemopoiesis. Baillieres Clin Haematol 1989; 2: 83–111.
Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Seghal PK, Nathan DG, Clark SC. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872–5.
Kindler V, Thorens B, deKossodo S, Allet B, Eliason JF, Thatcher D, Farber N, Vassalli P. Stimulation of hematopoiesis in vivo by recombinant murine interleukin-3. PNAS USA 1986; 83: 1001–5.
Lord BI, Molineux G, Testa NG, Kelly M, Sponcer E, Dexter TM. The kinetics response of haematopoietic precursor cells, in vivo, to highly purified, recombinant interleukin-3. Lymphokine Res 1986; 5: 97–100.
Bagby GC. Interleukin-1, stromal cells, granulopoiesis, and the inflammatory response. Biotheraphy 1989; 1: 255–260.
Stork LC, Peterson VM, Rundus CH, Robinson WA. Interleukin-1 enhances murine granulopoiesis in vivo. Exp Hematol 1988; 16: 163–7.
Zsebo KM, Yuschenkoff VN, Schiffers S, Chang D, McCall E, Dinarello CA, Brown MA, Altrock B, Bagby GC. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 1988; 71: 99–103.
Miller K, Atkinson HAC. The in vitro effect of trichothecenes on the immune system. Fd Chem Toxic 1986; 24: 545–9.
Holt PS, Corrier DE. LeLoach JR. Suppressive and enhancing effect of T-2 toxin on murine lymphocyte activation and interleukin 2 production. Immunopharm and Immunotoxicol 1988; 10: 365–85.
Estrov Z, Roifman C, Mills G, Grunberger T, Gelfand EW, Freedman MH. The regulatory role of interleukin 2-responsive T lymphocytes on human marrow granulopoiesis. Blood 1987; 69: 1161–6.
Iizuka Y, Endo M, Horikoshi A, Takeuchi J, Ohsima T. The influence of the supernatant obtained from a culture of IL-2-activated lymphocytes on human hematopoietic progenitors. Exp Hematol 1990; 18: 119–23.
Takahashi M, Oshimi K, Mizoguchi H. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha. Exp Hematol 1990; 18: 395–9.
Etrattinghausen SE, Moore JG, White DE, Patanias L, Young NS, Rosenberg SA. Hematologic effect of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 1987; 69: 1654–60.
Mosmann TR, Coffman RL. TH 1-cell and TH 2-cell-different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immun 1989; 7: 145–73.
About this article
Cite this article
Cukrová, V., Kurita, N. & Akao, M. An early effect of aflatoxin B1 administered in vivo on the growth of bone marrow CFU-GM and the production of some cytokines in rats. Mycopathologia 120, 113–119 (1992). https://doi.org/10.1007/BF00578296
- Aflatoxin B1
- colony-stimulating activity